Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis
RNA N6-methyladenosine is a key step of posttranscriptional modulation that is involved in governing gene expression. The m6A modification catalyzed by Mettl3 has been widely recognized as a critical epigenetic regulation process for tumorigenic properties in various cancer cell lines, including bla...
Main Authors: | Ganping Wang, Yarong Dai, Kang Li, Maosheng Cheng, Gan Xiong, Xiaochen Wang, Shuang Chen, Zhi Chen, Jianwen Chen, Xiuyun Xu, Rong-song Ling, Liang Peng, Demeng Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.627706/full |
Similar Items
-
Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis
by: Ganping Wang, et al.
Published: (2021-03-01) -
METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner
by: Jie Han, et al.
Published: (2019-06-01) -
Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N 6-methyladenosine of Notch1
by: Chaohui Gu, et al.
Published: (2019-11-01) -
The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development
by: Paulina Wigner, et al.
Published: (2021-04-01) -
Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer
by: Qiang Wang, et al.
Published: (2020-05-01)